{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:34:47Z","timestamp":1791398087578,"version":"4.3.3"},"reference-count":22,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J R Army Med Corps"],"accepted":{"date-parts":[[2018,3,14]]},"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Acute pain secondary to trauma is commonly encountered on the battlefield. The use of morphine to manage pain during combat has been well established since the 19th century. Despite this, there is relatively little research on analgesia use in this environment. This study aims to review the use and complications of morphine and other opioids during Operation HERRICK.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A database search of the Joint Theatre Trauma Registry was completed looking for all incidences of morphine, fentanyl or naloxone use from February 2007 to September 2014. Microsoft Excel was used to analyse the results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Opioid analgesia was administered to 5801 casualties. Morphine was administered 6742 times to 3808 patients. Fentanyl was administered 9672 times to 4318 patients. Naloxone was used 18 times on 14 patients, giving a complication rate of 0.24%. Opioid doses prior to naloxone administration range from 0 to 72\u2009mg of morphine and from 0 to 100 mcg of fentanyl. Four casualties (two local civilians and two coalition forces) received naloxone despite no recorded opioids being administered. Opium abuse was prevalent among the local population in Afghanistan, and this could explain the rationale behind two local national casualties receiving naloxone without any documented opioids being given.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The use of opioids in a battlefield environment is extremely safe. Complication rates are similar to previously published data which is reassuring. The efficacy of different opioids was not covered by this study, and further analysis is required, particularly following the introduction of oral transmucosal fentanyl citrate and the availability of novel non-opioid analgesics.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jramc-2017-000897","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T09:15:48Z","timestamp":1523006148000},"page":"328-331","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Opioid analgesia on the battlefield: a retrospective review of data from Operation HERRICK"],"prefix":"10.1136","volume":"164","author":[{"given":"Pip","family":"Lewis","sequence":"first","affiliation":[{"name":"Emergency Department, Imperial College Healthcare NHS Trust, London, UK"},{"name":"Academic Department of Military Emergency Medicine, Royal Centre for Defence Medicine, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wright","sequence":"additional","affiliation":[{"name":"Emergency Department, Imperial College Healthcare NHS Trust, London, UK"},{"name":"Academic Department of Military Emergency Medicine, Royal Centre for Defence Medicine, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hooper","sequence":"additional","affiliation":[{"name":"1700 Naval Air Squadron, RNAS Culdrose, Cornwall, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"2025081315030605000_164.5.328.1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJMoa0903326","article-title":"Morphine use after combat injury in iraq and post-traumatic stress disorder","volume":"362","author":"Holbrook","year":"2010","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025081315030605000_164.5.328.2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5435\/00124635-201102001-00002","article-title":"Battlefield orthopaedic injuries cause the majority of long-term disabilities","volume":"19 Suppl 1","author":"Cross","year":"2011","journal-title":"J Am Acad Orthop Surg"},{"key":"2025081315030605000_164.5.328.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(97)00061-4"},{"key":"2025081315030605000_164.5.328.4","doi-asserted-by":"publisher","DOI":"10.1682\/JRRD.2003.09.0397"},{"key":"2025081315030605000_164.5.328.5","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-155-01-15"},{"key":"2025081315030605000_164.5.328.6","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-155-01-16"},{"key":"2025081315030605000_164.5.328.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530070060031"},{"key":"2025081315030605000_164.5.328.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1944.62850170001007"},{"key":"2025081315030605000_164.5.328.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1202561"},{"key":"2025081315030605000_164.5.328.10","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-2013-000227"},{"key":"2025081315030605000_164.5.328.11","doi-asserted-by":"crossref","unstructured":"Rogers E , Wright C , King P . Fentanyl lozenge story part 2: from military procurement to package. J R Army Med Corps 2018 jramc-2017-000901\u2013-2015.doi:10.1136\/jramc-2017-000901","DOI":"10.1136\/jramc-2017-000901"},{"key":"2025081315030605000_164.5.328.12","unstructured":"Islamic Republic of Afghanistan Ministry of Counter Narcotics. Afghanistan opium survey. Afghanistan: Islamic Republic of Afghanistan Ministry of Counter Narcotics, 2014. (accessed 11 Nov 2017)."},{"key":"2025081315030605000_164.5.328.13","unstructured":"Islamic Republic of Afghanistan Ministry of Counter Narcotics. Afghanistan Drug Report 2012. Afghanistan: Islamic Republic of Afghanistan Ministry of Counter Narcotics, 2012. (accessed 11 Nov 2017)."},{"key":"2025081315030605000_164.5.328.14","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-156-04s-05"},{"key":"2025081315030605000_164.5.328.15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/TA.0000000000001481","article-title":"Battlefield pain management: a view of 17 years in Israel Defense Forces","volume":"83","author":"Benov","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"key":"2025081315030605000_164.5.328.16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7205\/MILMED-D-14-00383","article-title":"Prehospital and en route analgesic use in the combat setting: a prospectively designed, multicenter, observational study","volume":"180","author":"Petz","year":"2015","journal-title":"Mil Med"},{"key":"2025081315030605000_164.5.328.17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/TA.0000000000001715","article-title":"Measuring MEDEVAC: metrics for performance improvement","volume":"84","author":"Galvagno","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"2025081315030605000_164.5.328.18","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3182754674"},{"key":"2025081315030605000_164.5.328.19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7205\/MILMED-D-14-00257","article-title":"Prehospital pain medication use by U.S. Forces in Afghanistan","volume":"180","author":"Shackelford","year":"2015","journal-title":"Mil Med"},{"key":"2025081315030605000_164.5.328.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2009.00731.x"},{"key":"2025081315030605000_164.5.328.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2011.05.018"},{"key":"2025081315030605000_164.5.328.22","doi-asserted-by":"publisher","DOI":"10.1136\/jramc-158-03-08"}],"container-title":["Journal of the Royal Army Medical Corps"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jramc-2017-000897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T22:03:26Z","timestamp":1755122606000},"score":1,"resource":{"primary":{"URL":"https:\/\/militaryhealth.bmj.com\/lookup\/doi\/10.1136\/jramc-2017-000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,9,13]]},"published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1136\/jramc-2017-000897"],"URL":"https:\/\/doi.org\/10.1136\/jramc-2017-000897","relation":{},"ISSN":["0035-8665","2052-0468"],"issn-type":[{"value":"0035-8665","type":"print"},{"value":"2052-0468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]}}}